Gelfoam® , a product referred to patients presenting unilateral vocal fold paralysis, was applied to a female singer who showed glottic insufficiency by vocal fold atrophy and who needed urgently to proceed with her professional activities. The product was applied through percutaneous and translumination viae, in clinic, and followed by vocal assessments to confirm the efficacy of the treatment. There were realized two series with one year of interval, both with two applications, respectively 28 and 30 days. The result was positive allowing the patient to return to her activities and to conclude her work during the period that Gelfoam®, that was in progressive absorption, permitted a glottic coaptation compatible with the necessities of the voice use.
larynx; insufficiency; implant; Gelfoam®
